Brain natriuretic peptide (BNP) increases more proportionally than ANP after heart attacks and may be a better predictor of left ventricular function and long-term survival.
BNP rises more proportionallyBNP may increase proportionally more than ANP after heart attacks, making it a potentially superior biomarker
What the researchers found
Plasma BNP may increase proportionally more than ANP after acute myocardial infarction and chronic heart failure, potentially offering superior diagnostic and prognostic value.
Why it matters
Identifying the best blood biomarker for heart function after a heart attack helps clinicians make better treatment decisions and predict which patients are at highest risk.
How the study worked
Cohort study comparing plasma BNP, ANP, and N-terminal proANP as indicators of left ventricular systolic function and predictors of long-term survival in patients after acute myocardial infarction.
What this study cannot tell us
Cohort study design; details of sample size and follow-up duration not specified in abstract. Comparison methodology may vary from modern assay standards.
How to read the evidence
Moderate clinical evidence from a cohort study with prognostic outcomes. Contributes to the evidence base for BNP superiority over ANP as a cardiac marker.
When this study was published
Published in 1996, this study contributed to the evidence that eventually made BNP/NT-proBNP the standard cardiac biomarker worldwide.
The bigger picture
This study contributed to establishing BNP as the preferred natriuretic peptide marker in cardiology. BNP and NT-proBNP testing is now standard of care after heart attacks worldwide.
Questions still open
- What BNP threshold levels best predict poor outcomes after myocardial infarction?
- Can serial BNP measurements guide treatment decisions after heart attacks?
Common questions
What is BNP?
How is BNP used after a heart attack?
Read the original research
Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
Circulation, 93(11), 1963-9
Citation
Omland, T; Aakvaag, A; Bonarjee, V V; Caidahl, K; Lie, R T; Nilsen, D W; Sundsfjord, J A; Dickstein, K. (1996). Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.. Circulation, 93(11), 1963-9.